Presentation 1_Exploring therapeutic mechanism of Fuzhenghefuzhiyang Formula in psoriasis: inflammation and metabolism regulation.pdf

Presentation 1_Exploring therapeutic mechanism of Fuzhenghefuzhiyang Formula in psoriasis: inflammation and metabolism regulation.pdf

Background<p>Psoriasis is a long-term, immune-mediated inflammatory disorder of the skin, affecting about 2-3% of the global population with rising prevalence rates. Clinical practice has demonstrated that Fuzhenghefuzhiyang formula (FZHFZY), a topical medication applied Chinese herbal formula...

Полное описание

Сохранить в:

Библиографические подробности
Главный автор:	Bin Tang (56654) (author)
Другие авторы:	Chen Zhang (66790) (author), Yujie Yang (2327590) (author), Haixin Zhong (18240646) (author), Kexin Yang (9733218) (author), Hao Deng (409186) (author), Jingjie Yu (3549059) (author), Yonggen Chen (17964038) (author), Xiangliang Deng (8499348) (author), Chuanjian Lu (534232) (author), Haiming Chen (355433) (author)
Опубликовано:	2025
Предметы:	Genetic Immunology psoriasis FZHFZY transcriptomics metabolomics integrated analysis NLRP3
Метки:	Добавить метку Нет меток, Требуется 1-ая метка записи!

Схожие документы

Data Sheet 2_Sporoderm-removed ganoderma lucidum spore powder (S-GLSP) alleviates neuroinflammation injury by regulating microglial polarization through inhibition of NLRP3 inflammasome activation.pdf
по: Wenli Li (337819)
Опубликовано: (2025)

Data Sheet 1_Sporoderm-removed ganoderma lucidum spore powder (S-GLSP) alleviates neuroinflammation injury by regulating microglial polarization through inhibition of NLRP3 inflammasome activation.pdf
по: Wenli Li (337819)
Опубликовано: (2025)

Exploration of the Gas Adsorption/Selection Behavior and Its Doping Regulation Strategy of COFs for Improved Gas-Sensing Performance
по: Xuefeng Liang (3838222)
Опубликовано: (2025)

Exploration of the Gas Adsorption/Selection Behavior and Its Doping Regulation Strategy of COFs for Improved Gas-Sensing Performance
по: Xuefeng Liang (3838222)
Опубликовано: (2025)

Exploration of the Gas Adsorption/Selection Behavior and Its Doping Regulation Strategy of COFs for Improved Gas-Sensing Performance
по: Xuefeng Liang (3838222)
Опубликовано: (2025)

Exploration of the Gas Adsorption/Selection Behavior and Its Doping Regulation Strategy of COFs for Improved Gas-Sensing Performance
по: Xuefeng Liang (3838222)
Опубликовано: (2025)

Exploration of the Gas Adsorption/Selection Behavior and Its Doping Regulation Strategy of COFs for Improved Gas-Sensing Performance
по: Xuefeng Liang (3838222)
Опубликовано: (2025)

Exploration of the Gas Adsorption/Selection Behavior and Its Doping Regulation Strategy of COFs for Improved Gas-Sensing Performance
по: Xuefeng Liang (3838222)
Опубликовано: (2025)

Additional file 1 of Combined metabolome and transcriptome profiling provides insights into dynamic molecular control of lemon (Citrus Limon L.) peel development
по: Hongming Liu (631933)
Опубликовано: (2025)

Data Sheet 1_Transcriptome and metabolome analyses revealed the main profiles contributing the mild aroma characteristics of Artemisia stolonifera.docx
по: Ye Cao (849948)
Опубликовано: (2025)

Table 1_Melatonin mitigates cadmium-induced oxidative damage and modulates polysaccharide biosynthesis in Bletilla striata.xlsx
по: Deqiong Niu (19691873)
Опубликовано: (2025)

Data Sheet 1_Melatonin mitigates cadmium-induced oxidative damage and modulates polysaccharide biosynthesis in Bletilla striata.docx
по: Deqiong Niu (19691873)
Опубликовано: (2025)

Supplementary file 1_Metabolic reprogramming in PGPR reveals cross-feeding-driven physiological shifts and metabolic adaptations.docx
по: Kamogelo Mmotla (22674650)
Опубликовано: (2025)

Supplementary file 1_Drug combination discovery assisted by AI and untargeted metabolomics: pamiparib and anlotinib synergistic potentiation for ovarian cancer treatment.docx
по: Dong Wang (73290)
Опубликовано: (2025)

Integrating urinary metabolomics and clinical datasets for multi-cancer detection
по: Dongyong Lee (18786694)
Опубликовано: (2025)

Data Sheet 1_Exploring the stroke burden linked to Kidney dysfunction: trends, predictive insights, and health inequalities.pdf
по: Jiahao Tang (12360233)
Опубликовано: (2025)

Supplementary file 2_Clinical efficacy and metabolomics profiling of dachaihu decoction for patients with septic liver injury: a randomized controlled trial.doc
по: Zhen Yang (107412)
Опубликовано: (2025)

Supplementary file 1_Clinical efficacy and metabolomics profiling of dachaihu decoction for patients with septic liver injury: a randomized controlled trial.pdf
по: Zhen Yang (107412)
Опубликовано: (2025)

Supplementary file 4_Clinical efficacy and metabolomics profiling of dachaihu decoction for patients with septic liver injury: a randomized controlled trial.docx
по: Zhen Yang (107412)
Опубликовано: (2025)

Supplementary file 3_Clinical efficacy and metabolomics profiling of dachaihu decoction for patients with septic liver injury: a randomized controlled trial.docx
по: Zhen Yang (107412)
Опубликовано: (2025)

Quantitative Proteomics Links Mitochondrial Dysfunction to Metabolic Changes and Epithelial Differentiation Defects in Hyperoxia-Exposed Neonatal Airway Cells
по: Abhrajit Ganguly (21540245)
Опубликовано: (2025)

Table S2 from ASS1-Mediated Reductive Carboxylation of Cytosolic Glutamine Confers Ferroptosis Resistance in Cancer Cells
по: Qiangsheng Hu (15400215)
Опубликовано: (2025)

Table S3 from ASS1-Mediated Reductive Carboxylation of Cytosolic Glutamine Confers Ferroptosis Resistance in Cancer Cells
по: Qiangsheng Hu (15400215)
Опубликовано: (2025)

Supplementary Table S1 from Histone Methyltransferase NSD2 Activates PKCα to Drive Metabolic Reprogramming and Lenalidomide Resistance in Multiple Myeloma
по: Phyllis S.Y. Chong (17141520)
Опубликовано: (2025)

Supplementary Table S2 from Histone Methyltransferase NSD2 Activates PKCα to Drive Metabolic Reprogramming and Lenalidomide Resistance in Multiple Myeloma
по: Phyllis S.Y. Chong (17141520)
Опубликовано: (2025)

Supplementary Figure S1 from Obesity Is Associated with Altered Tumor Metabolism in Metastatic Melanoma
по: Andrew W. Hahn (15024693)
Опубликовано: (2025)

Supplementary Figure S2 from Obesity Is Associated with Altered Tumor Metabolism in Metastatic Melanoma
по: Andrew W. Hahn (15024693)
Опубликовано: (2025)

Supplementary Figure S3 from Obesity Is Associated with Altered Tumor Metabolism in Metastatic Melanoma
по: Andrew W. Hahn (15024693)
Опубликовано: (2025)

Supplementary Figure S4 from Obesity Is Associated with Altered Tumor Metabolism in Metastatic Melanoma
по: Andrew W. Hahn (15024693)
Опубликовано: (2025)

Supplementary Figure S5 from Obesity Is Associated with Altered Tumor Metabolism in Metastatic Melanoma
по: Andrew W. Hahn (15024693)
Опубликовано: (2025)

Supplementary Figure S6 from Obesity Is Associated with Altered Tumor Metabolism in Metastatic Melanoma
по: Andrew W. Hahn (15024693)
Опубликовано: (2025)

Supplementary Figure S7 from Obesity Is Associated with Altered Tumor Metabolism in Metastatic Melanoma
по: Andrew W. Hahn (15024693)
Опубликовано: (2025)

Supplementary Figure S8 from Obesity Is Associated with Altered Tumor Metabolism in Metastatic Melanoma
по: Andrew W. Hahn (15024693)
Опубликовано: (2025)

Supplementary Table 2 from Obesity Is Associated with Altered Tumor Metabolism in Metastatic Melanoma
по: Andrew W. Hahn (15024693)
Опубликовано: (2025)

Supplementary Table 3 from Obesity Is Associated with Altered Tumor Metabolism in Metastatic Melanoma
по: Andrew W. Hahn (15024693)
Опубликовано: (2025)

Supplementary Table 4 from Obesity Is Associated with Altered Tumor Metabolism in Metastatic Melanoma
по: Andrew W. Hahn (15024693)
Опубликовано: (2025)

Supplementary Table 5 from Obesity Is Associated with Altered Tumor Metabolism in Metastatic Melanoma
по: Andrew W. Hahn (15024693)
Опубликовано: (2025)

Figure 1 from Metabolomic Biomarkers in Blood Samples Identify Cancers in a Mixed Population of Patients with Nonspecific Symptoms
по: James R. Larkin (14936324)
Опубликовано: (2025)

Figure 2 from Metabolomic Biomarkers in Blood Samples Identify Cancers in a Mixed Population of Patients with Nonspecific Symptoms
по: James R. Larkin (14936324)
Опубликовано: (2025)

Figure 3 from Metabolomic Biomarkers in Blood Samples Identify Cancers in a Mixed Population of Patients with Nonspecific Symptoms
по: James R. Larkin (14936324)
Опубликовано: (2025)

Cannot write session to /tmp/vufind_sessions/sess_nn9oarh9bt8hfb1o08jj6pid7g